Financial Toxicity in Cancer Clinical Trials: An Issue in Need of Clarity and Solutions.
作者信息
Barksdale Elizabeth K S, Selig Wendy, DeCormier Plosky Willyanne, Miller Erin, McDonough Keri, Backler Chelsea, George Elizabeth, Fleury Mark E, Taylor Marc J, Pankevich Diana E, Murphy Jim, Hermann Kristin, Davis Leigh Ann, DeCotiis Gissoo, Gonzalez-Cerimele Cecile, Cook Colleen, Shaw Sandra, Gelinas Luke, Dornsife Dana L, Bierer Barbara E, Gerber David E
机构信息
LUNGevity Foundation, Chicago, IL.
WSCollaborative, McLean, VA.
出版信息
J Clin Oncol. 2025 Jul 10;43(20):2231-2238. doi: 10.1200/JCO-24-01577. Epub 2025 May 12.
Abstract
摘要
相似文献
1
Financial Toxicity in Cancer Clinical Trials: An Issue in Need of Clarity and Solutions.癌症临床试验中的经济毒性：一个需要明确和解决的问题。
J Clin Oncol. 2025 Jul 10;43(20):2231-2238. doi: 10.1200/JCO-24-01577. Epub 2025 May 12.
2
Washout policies in long-term indwelling urinary catheterisation in adults.成人长期留置导尿的冲洗策略。
Cochrane Database Syst Rev. 2017 Mar 6;3(3):CD004012. doi: 10.1002/14651858.CD004012.pub5.
3
"Financial Stability": A Nightmare for Retired Healthcare Professionals in Southwestern Nigeria: An Interpretative Phenomenology.“金融稳定”：尼日利亚西南部退休医疗专业人员的噩梦：一项诠释现象学研究
SAGE Open Nurs. 2025 Jun 17;11:23779608251350235. doi: 10.1177/23779608251350235. eCollection 2025 Jan-Dec.
4
An overview of reviews evaluating the effectiveness of financial incentives in changing healthcare professional behaviours and patient outcomes.评估经济激励措施在改变医疗保健专业人员行为和患者结局方面有效性的综述概述。
Cochrane Database Syst Rev. 2011 Jul 6;2011(7):CD009255. doi: 10.1002/14651858.CD009255.
5
Clarity AD: Asian regional analysis of a phase III trial of lecanemab in early Alzheimer's disease.CLARITY AD：早期阿尔茨海默病中lecanemab的III期试验亚洲区域分析
J Prev Alzheimers Dis. 2025 May;12(5):100160. doi: 10.1016/j.tjpad.2025.100160. Epub 2025 Apr 5.
6
Comprehensive Score for Financial Toxicity and Health-Related Quality of Life in Patients With Cancer and Survivors: A Systematic Review and Meta-Analysis.癌症患者和幸存者的财务毒性和健康相关生活质量综合评分：系统评价和荟萃分析。
Value Health. 2023 Feb;26(2):300-316. doi: 10.1016/j.jval.2022.07.017. Epub 2022 Sep 5.
7
Chemotherapy for hormone-refractory prostate cancer.激素难治性前列腺癌的化疗
Cochrane Database Syst Rev. 2006 Oct 18(4):CD005247. doi: 10.1002/14651858.CD005247.pub2.
8
Washout policies in long-term indwelling urinary catheterisation in adults.成人长期留置导尿的拔管策略。
Cochrane Database Syst Rev. 2010 Mar 17(3):CD004012. doi: 10.1002/14651858.CD004012.pub4.
9
Interventions targeted at women to encourage the uptake of cervical screening.针对女性的干预措施，以鼓励她们接受宫颈癌筛查。
Cochrane Database Syst Rev. 2021 Sep 6;9(9):CD002834. doi: 10.1002/14651858.CD002834.pub3.
10
Non-resection versus resection for an asymptomatic primary tumour in patients with unresectable stage IV colorectal cancer.不可切除的IV期结直肠癌患者无症状原发性肿瘤的非切除与切除治疗比较
Cochrane Database Syst Rev. 2012 Aug 15;2012(8):CD008997. doi: 10.1002/14651858.CD008997.pub2.
本文引用的文献
1
Financial Toxicity Has Never Been More Important in Cancer Care: How Do We Measure It?
JCO Oncol Pract. 2025 Jan;21(1):52-56. doi: 10.1200/OP.24.00162. Epub 2025 Jan 10.
2
Associations of Financial Hardship and Health Status, Social Functioning, and Mental Health Among Cancer Survivors in the United States: Findings From a Nationally Representative Study.美国癌症幸存者的经济困难与健康状况、社会功能及心理健康的关联：一项全国代表性研究的结果
JCO Oncol Pract. 2025 Jan;21(1):78-88. doi: 10.1200/OP.23.00833. Epub 2025 Jan 10.
3
Development and Validation of a Simplified Financial Toxicity Screening Tool for Use in Clinical Practice.一种用于临床实践的简化财务毒性筛查工具的开发与验证
JCO Oncol Pract. 2025 Jan;21(1):12-19. doi: 10.1200/OP-24-00598. Epub 2025 Jan 10.
4
Cost Conversations to Mitigate the Effects of Financial Toxicity in Oncology: Current State, Opportunities, and Barriers.减轻肿瘤学中财务毒性影响的成本对话：现状、机遇与障碍
JCO Oncol Pract. 2025 Jan;21(1):23-28. doi: 10.1200/OP-24-00454. Epub 2025 Jan 10.
5
Financial Toxicity in Cancer Care: Where Are We, and How Did We Get Here? Introduction to a Special Series.
JCO Oncol Pract. 2025 Jan;21(1):1-3. doi: 10.1200/OP-24-00793. Epub 2025 Jan 10.
6
Approaches to Continuing COVID-19-Related Clinical Research Practices After the Pandemic-Must Cinderella Leave the Ball?疫情后继续开展与新冠病毒相关临床研究实践的方法——灰姑娘必须离开舞会吗？
JAMA Oncol. 2023 Aug 1;9(8):1027-1028. doi: 10.1001/jamaoncol.2023.1514.
7
Influence of Cost-Related Considerations on Clinical Trial Participation: Results from the 2020 Health Information National Trends Survey (HINTS).费用相关因素对临床试验参与的影响：来自 2020 年健康信息全国趋势调查（HINTS）的结果。
J Gen Intern Med. 2023 Apr;38(5):1200-1206. doi: 10.1007/s11606-022-07801-0. Epub 2022 Nov 30.
8
Enhancing access to and diversity in cancer clinical trials through a financial reimbursement program: Protocol to evaluate a novel program.通过财务报销计划提高癌症临床试验的可及性和多样性：评估新计划的方案。
Contemp Clin Trials. 2022 Oct;121:106922. doi: 10.1016/j.cct.2022.106922. Epub 2022 Sep 10.
9
The cost of cancer care: how far would you go for a trial?癌症治疗费用：你愿意为临床试验走多远？
Ir J Med Sci. 2022 Dec;191(6):2487-2491. doi: 10.1007/s11845-021-02915-6. Epub 2022 Jan 17.
10
Patient-Reported Out-of-Pocket Costs and Financial Toxicity During Early-Phase Oncology Clinical Trials.患者报告的自费支出和肿瘤学早期临床试验期间的财务毒性
Oncologist. 2021 Jul;26(7):588-596. doi: 10.1002/onco.13767. Epub 2021 Apr 21.
Zotero 插件